Nothing Special   »   [go: up one dir, main page]

HK1071366A1 - Compounds which inhibit the release of inflammatory cytokines - Google Patents

Compounds which inhibit the release of inflammatory cytokines

Info

Publication number
HK1071366A1
HK1071366A1 HK05104163A HK05104163A HK1071366A1 HK 1071366 A1 HK1071366 A1 HK 1071366A1 HK 05104163 A HK05104163 A HK 05104163A HK 05104163 A HK05104163 A HK 05104163A HK 1071366 A1 HK1071366 A1 HK 1071366A1
Authority
HK
Hong Kong
Prior art keywords
substituted
compounds
inflammatory cytokines
release
unsubstituted
Prior art date
Application number
HK05104163A
Other languages
English (en)
Inventor
Michael Phillip Clark
Matthew John Laufer-Sweiler
Jane Far-Jine Djung
Biswanath De
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of HK1071366A1 publication Critical patent/HK1071366A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/20Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HK05104163A 2001-09-20 2005-05-18 Compounds which inhibit the release of inflammatory cytokines HK1071366A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32362501P 2001-09-20 2001-09-20
PCT/US2002/030134 WO2003024970A1 (en) 2001-09-20 2002-09-20 Compounds which inhibit the release of inflammatory cytokines

Publications (1)

Publication Number Publication Date
HK1071366A1 true HK1071366A1 (en) 2005-07-15

Family

ID=23259997

Family Applications (2)

Application Number Title Priority Date Filing Date
HK05104163A HK1071366A1 (en) 2001-09-20 2005-05-18 Compounds which inhibit the release of inflammatory cytokines
HK05104374A HK1071565A1 (en) 2001-09-20 2005-05-24 6,7-Dihydro-5H-pyrazolo Ä1,2-AÜ pyrazol-1-ones which control inflammatory cytokines

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK05104374A HK1071565A1 (en) 2001-09-20 2005-05-24 6,7-Dihydro-5H-pyrazolo Ä1,2-AÜ pyrazol-1-ones which control inflammatory cytokines

Country Status (33)

Country Link
US (2) US6821971B2 (xx)
EP (3) EP1427732B1 (xx)
JP (3) JP2005504083A (xx)
KR (4) KR20060036125A (xx)
CN (3) CN1250551C (xx)
AR (3) AR037237A1 (xx)
AT (3) ATE356126T1 (xx)
AU (2) AU2002327690B2 (xx)
BR (3) BR0212673A (xx)
CA (3) CA2461071A1 (xx)
CO (3) CO5560589A2 (xx)
CY (1) CY1106398T1 (xx)
CZ (3) CZ2004358A3 (xx)
DE (3) DE60213108T2 (xx)
DK (2) DK1427728T3 (xx)
EG (2) EG24363A (xx)
ES (3) ES2268154T3 (xx)
HK (2) HK1071366A1 (xx)
HU (3) HUP0402378A3 (xx)
IL (3) IL160682A0 (xx)
MA (3) MA27066A1 (xx)
MX (3) MXPA04002569A (xx)
MY (2) MY129329A (xx)
NO (2) NO20041594L (xx)
NZ (3) NZ531063A (xx)
PE (3) PE20030446A1 (xx)
PL (3) PL370415A1 (xx)
PT (3) PT1427728E (xx)
RU (3) RU2278864C2 (xx)
SA (1) SA03230529B1 (xx)
SK (3) SK1492004A3 (xx)
WO (3) WO2003024973A1 (xx)
ZA (3) ZA200401260B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US7087615B2 (en) 2001-09-20 2006-08-08 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which provide analgesia
US6849627B2 (en) 2001-09-20 2005-02-01 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US7473695B2 (en) * 2001-10-22 2009-01-06 Mitsubishi Tanabe Pharma Corporation 4-imidazolin-2-one compounds
US6677337B2 (en) * 2002-03-19 2004-01-13 The Procter & Gamble Company 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines
ATE355839T1 (de) * 2002-09-09 2007-03-15 Amgen Inc 1,4,5-substituierte 1,2-dihydro-pyrazol-3-one and 3-alkoxy-1h-pyrazole derivate als tnf-alpha und interleukin senkende wirkstoffe zur behandlung von entzündungen
DE502004003688D1 (de) * 2003-04-03 2007-06-14 Merck Patent Gmbh Pyrazolidin-1,2-dicarbonsäure-1-((phenyl)-amid)-2-((phenyl)-amid) derivate als koagulationsfaktor xa inhibitoren zur behandlung von thrombosen
GB0308466D0 (en) * 2003-04-11 2003-05-21 Novartis Ag Organic compounds
US7482356B2 (en) * 2003-11-10 2009-01-27 The Procter & Gamble Company Bicyclic pyrazolone cytokine inhibitors
AU2007238071B2 (en) * 2006-04-18 2012-06-07 Abbvie Inc. Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
EP2432767B1 (en) * 2009-05-19 2013-06-26 Dow AgroSciences LLC Compounds and methods for controlling fungi
WO2016205284A1 (en) 2015-06-15 2016-12-22 Cummins Inc. Combustion chamber elasticity device
US20190060286A1 (en) 2016-02-29 2019-02-28 University Of Florida Research Foundation, Incorpo Chemotherapeutic Methods
CN107033090B (zh) * 2017-05-16 2019-05-07 无锡捷化医药科技有限公司 一种1,2,3,4-四氢噌啉的制备方法
RU2721684C1 (ru) * 2019-09-06 2020-05-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" Метил 2,3,8-триоксо-4-фенилтетрагидро-6Н-пиразоло[1,2-а]пирроло[2,3-c]пиразол-9а(1Н)-карбоксилаты
EP4422621A1 (en) * 2021-10-27 2024-09-04 Merck Sharp & Dohme LLC Spirotricycle ripk1 inhibitors and methods of uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054291A (xx) * 1963-02-26
GB1124982A (en) * 1965-02-09 1968-08-21 Lepetit Spa Diazabicyclo octanes and derivatives thereof
CH529153A (fr) 1969-10-27 1972-10-15 Lepetit Spa Procédé de préparation de pyrazolo (1,2-b) phtalazine-1,5 (10H)-diones
US5358924A (en) * 1991-03-21 1994-10-25 Bayer Aktiengesellschaft 3-hydroxy-4-aryl-5-oxo-pyrozoline derivatives, compositions and use
PL202547B1 (pl) * 1999-09-07 2009-07-31 Syngenta Participations Ag Chwastobójczo działające związki heterocykliczne podstawione grupą fenylową, środek chwastobójczy i powstrzymujący wzrost roślin, selektywny środek chwastobójczy oraz sposób selektywnego zwalczania chwastów i traw w uprawach roślin użytkowych
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines

Also Published As

Publication number Publication date
AR037145A1 (es) 2004-10-27
CO5560590A2 (es) 2005-09-30
ZA200401260B (en) 2004-08-30
HK1071565A1 (en) 2005-07-22
WO2003024971A1 (en) 2003-03-27
PL370415A1 (en) 2005-05-30
EP1427732B1 (en) 2006-07-12
CN1555379A (zh) 2004-12-15
HUP0500752A2 (en) 2006-01-30
CO5560579A2 (es) 2005-09-30
MA27064A1 (fr) 2004-12-20
HUP0402378A3 (en) 2008-10-28
DE60202782T2 (de) 2006-01-19
DE60218704D1 (de) 2007-04-19
DE60213108T2 (de) 2007-02-08
SK1502004A3 (en) 2004-09-08
NZ531123A (en) 2006-08-31
JP2005504082A (ja) 2005-02-10
HUP0402500A2 (hu) 2005-03-29
SK1492004A3 (en) 2004-11-03
CZ2004361A3 (cs) 2004-07-14
MA27065A1 (fr) 2004-12-20
ATE356126T1 (de) 2007-03-15
BR0212716A (pt) 2004-08-03
ATE332901T1 (de) 2006-08-15
AU2002334641B2 (en) 2007-03-29
CN1257905C (zh) 2006-05-31
NZ531122A (en) 2005-09-30
ES2282459T3 (es) 2007-10-16
RU2278864C2 (ru) 2006-06-27
CZ2004345A3 (cs) 2004-06-16
PE20030446A1 (es) 2003-07-21
RU2004111803A (ru) 2005-10-10
PE20030430A1 (es) 2003-06-24
WO2003024970A1 (en) 2003-03-27
DK1427732T3 (da) 2006-10-30
MXPA04002570A (es) 2004-05-31
WO2003024973A1 (en) 2003-03-27
CA2461073A1 (en) 2003-03-27
DE60213108D1 (de) 2006-08-24
NO20041605L (no) 2004-06-21
EP1427727B1 (en) 2005-01-26
EP1427728B1 (en) 2007-03-07
PT1427732E (pt) 2006-12-29
MA27066A1 (fr) 2004-12-20
MXPA04002569A (es) 2004-05-31
MY129329A (en) 2007-03-30
EP1427728A1 (en) 2004-06-16
EP1427732A1 (en) 2004-06-16
SA03230529B1 (ar) 2008-06-21
RU2004111806A (ru) 2005-03-27
DE60218704T2 (de) 2007-11-08
HUP0402500A3 (en) 2008-10-28
KR100623879B1 (ko) 2006-09-19
PT1427728E (pt) 2007-05-31
NO20041594L (no) 2004-06-21
PL370351A1 (en) 2005-05-16
US20030105084A1 (en) 2003-06-05
PE20030474A1 (es) 2003-07-22
EP1427727A1 (en) 2004-06-16
JP2005504081A (ja) 2005-02-10
RU2299885C2 (ru) 2007-05-27
KR20040035836A (ko) 2004-04-29
MXPA04002574A (es) 2004-06-18
ATE287887T1 (de) 2005-02-15
IL160741A0 (en) 2004-08-31
KR20040035837A (ko) 2004-04-29
KR100656126B1 (ko) 2006-12-12
US6821971B2 (en) 2004-11-23
KR20060036125A (ko) 2006-04-27
CN1555375A (zh) 2004-12-15
CN1250551C (zh) 2006-04-12
MY129069A (en) 2007-03-30
KR20040035835A (ko) 2004-04-29
EG24363A (en) 2009-03-04
PL370362A1 (en) 2005-05-16
CZ2004358A3 (cs) 2004-07-14
ZA200401403B (en) 2004-08-30
AR037237A1 (es) 2004-11-03
BR0212673A (pt) 2004-08-24
JP2005504083A (ja) 2005-02-10
IL160742A0 (en) 2004-08-31
SK1482004A3 (en) 2004-08-03
IL160682A0 (en) 2004-08-31
CN1556811A (zh) 2004-12-22
ES2237691T3 (es) 2005-08-01
PT1427727E (pt) 2005-06-30
DK1427728T3 (da) 2007-07-09
RU2272040C2 (ru) 2006-03-20
CA2461072A1 (en) 2003-03-27
NZ531063A (en) 2007-08-31
HUP0402378A2 (hu) 2005-02-28
ZA200401402B (en) 2004-08-27
CA2461071A1 (en) 2003-03-27
AU2002327690B2 (en) 2006-07-20
AR037502A1 (es) 2004-11-17
CY1106398T1 (el) 2011-10-12
ES2268154T3 (es) 2007-03-16
RU2004111805A (ru) 2005-04-10
DE60202782D1 (de) 2005-03-03
BR0212905A (pt) 2004-10-13
CN1249066C (zh) 2006-04-05
EG24413A (en) 2009-05-25
US6566357B1 (en) 2003-05-20
CO5560589A2 (es) 2005-09-30

Similar Documents

Publication Publication Date Title
HK1071366A1 (en) Compounds which inhibit the release of inflammatory cytokines
WO2003045929A1 (fr) Derive bicyclique, procede de production de ce derive et utilisation correspondante
UA83243C2 (ru) Соединения, которые ингибируют натриезависимый переносчик глюкозы
EP1829858A3 (en) Dibenzylamine compounds and pharmaceutical use thereof
AU2268302A (en) Inhibitors against the production and release of inflammatory cytokines
WO2002089800A3 (en) N-aroyl cyclic amine derivatives as orexin receptor antagonists
WO2005092858A3 (en) Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist
HK1051858A1 (en) Novel cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof.
HRP20030566B1 (en) Improved process for carbapenem synthesis
EP1364950A4 (en) PYRIDOPYRIMIDINE OR NAPHTHYRIDINE DERIVATIVE
MY134226A (en) 1,2-dihydropyrazol-3-ones which control inflammatory cyctokines
IS7911A (is) Ímídasólafleiður með sækni í alfa 2 viðtakavirkni
NO20023298D0 (no) Nye imidazolderivater
CA2377233A1 (en) Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof
NO20041601L (no) Forbindelse som hemmer frigjøringen av inflammatoriske cytokiner
MX2022007947A (es) Derivado de amida de acido alifatico.
TW200510300A (en) Amino alcohol compounds
EP1197493A4 (en) benzimidazole

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100920